Insider · CIK 0001168060

NIVEN RALPH

Reports to the SEC for 3 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001168060

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-02-05	JBIOJade Biosciences, Inc.M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	+1,400 sh	$1.74	+$2,436	3,009
2024-02-05	JBIOJade Biosciences, Inc.M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	+3,200 sh	$2.14	+$6,848	6,209
2024-02-05	JBIOJade Biosciences, Inc.S Sale	CHIEF SCIENTIFIC OFFICER	SSale	−4,600 sh	$17.45	−$80.2K	1,609
2024-02-05	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−900 sh	—	—	13,308
2024-02-05	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−500 sh	—	—	9,088
2024-02-05	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−500 sh	—	—	10,894
2024-02-05	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−1,200 sh	—	—	34,908
2024-02-05	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−1,500 sh	—	—	41,732
2024-01-22	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)A Award	CHIEF SCIENTIFIC OFFICER	AAward	+66.6K sh	—	—	66,586
2024-01-05	JBIOJade Biosciences, Inc.M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	+1,400 sh	$1.74	+$2,436	3,009
2024-01-05	JBIOJade Biosciences, Inc.M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	+3,200 sh	$2.14	+$6,848	6,209
2024-01-05	JBIOJade Biosciences, Inc.S Sale	CHIEF SCIENTIFIC OFFICER	SSale	−2,126 sh	$18.67	−$39.7K	4,083
2024-01-05	JBIOJade Biosciences, Inc.S Sale	CHIEF SCIENTIFIC OFFICER	SSale	−2,474 sh	$19.57	−$48.4K	1,609
2024-01-05	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−900 sh	—	—	14,208
2024-01-05	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−500 sh	—	—	9,588
2024-01-05	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−500 sh	—	—	11,394
2024-01-05	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−1,200 sh	—	—	36,108
2024-01-05	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−1,500 sh	—	—	43,232
2023-12-05	JBIOJade Biosciences, Inc.M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	+1,400 sh	$1.74	+$2,436	3,009
2023-12-05	JBIOJade Biosciences, Inc.M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	+3,200 sh	$2.14	+$6,848	6,209
2023-12-05	JBIOJade Biosciences, Inc.S Sale	CHIEF SCIENTIFIC OFFICER	SSale	−4,600 sh	$16.30	−$75K	1,609
2023-12-05	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−900 sh	—	—	15,108
2023-12-05	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−500 sh	—	—	10,088
2023-12-05	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−500 sh	—	—	11,894
2023-12-05	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−1,200 sh	—	—	37,308
2023-12-05	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−1,500 sh	—	—	44,732
2023-11-22	JBIOJade Biosciences, Inc.M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	+4,200 sh	$1.74	+$7,308	5,809
2023-11-22	JBIOJade Biosciences, Inc.M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	+9,600 sh	$2.14	+$20.5K	15,409
2023-11-22	JBIOJade Biosciences, Inc.S Sale	CHIEF SCIENTIFIC OFFICER	SSale	−13.8K sh	$15.00	−$207K	1,609
2023-11-22	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−2,700 sh	—	—	16,008
2023-11-22	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−1,500 sh	—	—	10,588
2023-11-22	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−1,500 sh	—	—	12,394
2023-11-22	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−3,600 sh	—	—	38,508
2023-11-22	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−4,500 sh	—	—	46,232
2023-07-05	JBIOJade Biosciences, Inc.M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	+650 sh	$1.74	+$1,131	2,259
2023-07-05	JBIOJade Biosciences, Inc.M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	+1,600 sh	$2.14	+$3,424	3,859
2023-07-05	JBIOJade Biosciences, Inc.S Sale	CHIEF SCIENTIFIC OFFICER	SSale	−2,031 sh	$17.23	−$35K	1,828
2023-07-05	JBIOJade Biosciences, Inc.S Sale	CHIEF SCIENTIFIC OFFICER	SSale	−219 sh	$17.87	−$3,913.223	1,609
2023-07-05	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−450 sh	—	—	18,708
2023-07-05	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−200 sh	—	—	12,088
2023-07-05	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−200 sh	—	—	13,894
2023-07-05	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−650 sh	—	—	42,108
2023-07-05	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−750 sh	—	—	50,732
2023-06-05	JBIOJade Biosciences, Inc.M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	+650 sh	$1.74	+$1,131	2,259
2023-06-05	JBIOJade Biosciences, Inc.M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	+1,600 sh	$2.14	+$3,424	3,859
2023-06-05	JBIOJade Biosciences, Inc.S Sale	CHIEF SCIENTIFIC OFFICER	SSale	−2,250 sh	$16.26	−$36.6K	1,609
2023-06-05	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−450 sh	—	—	19,158
2023-06-05	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−200 sh	—	—	12,288
2023-06-05	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−200 sh	—	—	14,094
2023-06-05	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF SCIENTIFIC OFFICER	MExercise/Conversion	−650 sh	—	—	42,758

Recent filings

Accepted (ET)
Feb 74
NIVEN RALPH0001415889-24-002957
SEC(opens sec.gov)
Jan 244
NIVEN RALPH0001415889-24-001775
SEC(opens sec.gov)
Jan 84
NIVEN RALPH0001415889-24-000818
SEC(opens sec.gov)
Dec 74
NIVEN RALPH0001415889-23-015987
SEC(opens sec.gov)

Companies

Address

C/O AEROVATE THERAPEUTICS, INC. 200 BERKELEY STREET, FLOOR 18

BOSTON, MA, 02116